Lazaroids prevent acute cyclosporine-induced renal vasoconstriction

Transplantation

Volumn 63, Issue 9, 1997, Pages 1215-1220

  Krysztopik, Richard J ^a   Bentley, Frederick R ^a   Spain, David A ^a,b   Wilson, Mark A ^a,b   Garrison, R Neal ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ANTIOXIDANT; CITRIC ACID; CYCLOSPORIN A; DRUG VEHICLE; LAZAROID; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYDRONEPHROSIS; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENOVASCULAR DISEASE; REPERFUSION INJURY; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

ANIMALS; ANTIOXIDANTS; CYCLOSPORINE; HEMODYNAMIC PROCESSES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; PREGNATRIENES; RATS; RATS, WISTAR; RENAL CIRCULATION;

EID: 0030984816     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00005     Document Type: Article

References (42)

1. Puschett JB, Greenberg A, Holley J, McCauley J. The spectrum of cyclosporine nephrotoxicity. Am J Nephrol 1990; 10: 296.
2. Sutherland DER, Fry DS, Strand MH. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin in renal allograft recipients. Am J Kidney Dis 1985; 5: 318.
3. Gordon RD, Iwatsuki S, Shaw BWJ. Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants. Am J Kidney Dis 1985; 5: 307.
4. Abraham JS, Bentley FR, Garrison RN, Cryer HM. Cyclosporine A directly constricts intrarenal arterioles. Transplant Proc 1991; 23: 356.
5. Bloom IT, Bentley FR, Garrison RN. Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. Surgery 1993; 114: 480.
6. Abraham JS, Bentley FR, Garrison RN. The role of intrarenal prostaglandins and angiotensin II in acute cyclosporine-induced vasoconstriction. Surgery 1991; 110: 434.
7. Suleymanlar G, Suleymanlar I, Shapiro JI, Chan L. Possible role of lipid peroxidation in cyclosporine nephrotoxicity in rats. Transplant Proc 1994; 26: 2888.
8. Wolf A, Trendelenburg CF, Diez-Fernandez C, Prieto P, Cordier A. Role of glutathione in cyclosporine A in vitro hepatotoxicity. Transplant Proc 1994; 26: 2912.
9. Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporine-A-mediated impairment of renal functions. Transplant Proc 1994; 26: 2902.
10. Walker RJ, Lazzaro VA, Duggin GG, Horvath JS, Tiller DJ. Evidence that alterations in renal metabolism and lipid peroxidation may contribute to cyclosporine nephrotoxicity. Transplantation 1990; 50: 487.
11. Isoyama T, Sato T, Tanaka J, Jones RT. Measurement of cardiac output in small animals by aortic thermodilution. J Surg Res 1982; 33: 170.
12. Kahan BD. Cyclosporine nephrotoxicity: pathogenesis, prophylaxis, therapy and prognosis. Am J Kidney Dis 1986; 8: 323.
13. Walker PD, Das C, Shah SV. Cyclosporine A induced lipid peroxidation in renal cortical mitochondria. Kidney Int 1986; 29: 311.
14. Kehrer J. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21.
15. Inselmann G, Hannemann J, Baumann K. Cyclosporine A induced lipid peroxidation and influence on glucose-6-phosphate in rat hepatic and renal microsomes. Res Commun Chem Pathol Pharmacol 1990; 68: 189.
16. Wang C, Saluhudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int 1995; 47: 927.
17. Perico N, Ruggenenti P, Gaspari F, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54: 56.
18. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940.
19. Braughler JM, Pregenzer JF. The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Radic Biol Med 1989; 7: 125.
20. Shackleton RS, Ettinger SL, Scudamore CH, Toleikis PF, Keown PA. Effect of a 21-aminosteroid, U74006F, on lipid peroxidation and glomerulotubular function following experimental renal ischaemia. J Surg Res 1994; 57: 433.
21. Badylak SF, Lantz GC, Jeffries M. Prevention of reperfusion injury in surgically induced gastric dilatation volvulus in dogs. Am J Vet Res 1990; 51: 294.
22. Stanley JJ, Goldblum JR, Frank TS, Zelenock GB, D'Alecy LD. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F. J Vase Surg 1993; 17: 685.
23. Burke MD, Whiting PH. The role of drug metabolism in cyclosporine A nephrotoxicity. Clin Nephrol 1986; 25 (Suppl): 111.
24. Serino F, Grevel J, Kahan BD, Strobel HW. Oxygen radical formation by the cytochrome P-450 system as a cellular mechanism for cyclosporine toxicity. Transplant Proc 1994; 26: 2916.
25. Ahmed SS, Strobel HW, Napoli KL, Grevel J. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. J Pharmacol Exp Ther 1993; 265: 1047.
26. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412.
27. Galat JA, Robinson AV, Rhodes RS. Oxygen free radical mediated renal dysfunction. J Surg Res 1989; 46: 520.
28. Andreoli SP, McAteer JA. Reactive oxygen molecule-mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int 1990; 38: 785.
29. Maridonneau-Parini I, Fradin A, Touqui L, Russo-Marie F. Effect of intracellular oxygen-free radicals on the formation of lipid derived mediators in rat renomedullary interstitial cells. Biochem Pharmacol 1985; 34: 4137.
30. 2 glomerular synthesis. J Lipid Res 1995; 36: 260.
31. Morrow JD, Hill KE, Burk RF, Nammour RM, Badr KF, Roberts KJI. A series of prostaglandin FR-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383.
32. 2 receptors. J Clin Invest 1992; 90: 136.
33. Cotterill LA, Gower JD, Fuller BJ, Green GJ. Oxidative damage to the kidney membranes during cold ischemia, evidence of a role for calcium. Transplantation 1989; 48: 745.
34. 2 during cold storage of the rabbit kidney. Adv Exp Med Biol 1990; 264: 397.
35. Davidson I, Rooth P, Fry WR. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 1989; 48: 575.
36. 2 in cyclosporine A nephrotoxicity. Kidney Int 1988; 34: 164.
37. Kuo PC. Cyclosporine increases hepatocyte-synthesis of the immunosuppressive free radical nitric oxide. Transplant Proc 1994; 26: 2910.
38. Beckman JS, Beckman TW, Chen J. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 120.
39. Myers SI, Hernandez R, Castaneda A. Possible role for oxygen free radicals in the regulation of renal nitric oxide synthesis and blood flow. Am J Surg 1995; 169: 604.
40. Spain DA, Wilson MA, Garrison RN. Nitric oxide synthase inhibition exacerbates sepsis induced renal hypoperfusion. Surgery 1994; 116: 3221.
41. tT-20) cells. J Pharmacol Exp Ther 1988; 244: 423.
42. 2 release is restored by treatment with lazaroid. Prostaglandins 1993; 45: 535.